Modified VISTA in Myeloma

(00:03:29) Elsevier Global Medical News, 2009 Dec 7, JS MacNeil

Dr. Maria-Victoria Mateos is from the Hospital Universitario de Salamanca in Spain.

Melphalan showed itself to be a better partner than thalidomide for induction with bortezomib for the treatment of elderly patients with multiple myeloma in a randomized phase III trial reported by lead investigator Dr. Mateos in the plenary session at ASH 2009. 

See related videos to:
ASH 2009

Related Link:

News Article: Modified VISTA Regimen Easier on Elderly With Multiple Myeloma »

Copyright © 2010 International Medical News Group
Subscribe Now »